Show simple item record

dc.contributor.authorMichel, Michelle Estellaen_US
dc.date.accessioned2015-08-04T15:56:43Z
dc.date.available2015-08-04T15:56:43Z
dc.date.issued2013
dc.date.submitted2013
dc.identifier.other
dc.identifier.urihttps://hdl.handle.net/2144/12161
dc.descriptionThesis (M.A.)--Boston Universityen_US
dc.description.abstractBackground: Pregnancy-related health complications can pose imminent threats to the health of both mother and fetus. Gestational hypertension accompanied by proteinuria after 20 weeks’ gestation characterize the condition known as preeclampsia, which puts mothers and their fetuses at risk for a number of adverse outcomes. Significance: From 1987 to 2004, the incidence of preeclampsia rose by 25%. Adverse outcomes in the mother-to-be include preterm delivery, acute renal failure and maternal death. As a result of preeclampsia, the fetus can suffer intrauterine growth restriction, preterm birth and low birth weight. Aim: Researchers have explored a number of strategies to predict, prevent and manage preeclampsia. This work will explore the various strategies employed and documented in the literature. Conclusion: Treatments that may be beneficial for the mother (delivering the infant), may not necessarily be beneficial for the fetus (may have a young gestational age) and vice versa. Therefore, determining the appropriate method of handling each case of preeclampsia is critical to the work of the obstetrician, and should be decided from evidence-based treatments and management.en_US
dc.language.isoen_US
dc.publisherBoston Universityen_US
dc.titlePrediction, prevention and management of preeclampsiaen_US
dc.typeThesis/Dissertationen_US
etd.degree.nameMaster of Artsen_US
etd.degree.levelmastersen_US
etd.degree.disciplineMedical Sciencesen_US
etd.degree.grantorBoston Universityen_US


This item appears in the following Collection(s)

Show simple item record